shutterstock_1538718899 crop 3 copy.jpg

DISSOLVING
MICRONEEDLE
PLATFORM

University Medical is in pre-clinical development of stable, painless and simple vaccine and drug delivery via novel, dissolving Microneedle arrays.
shutterstock_711675304.jpg
shutterstock_126116831.jpg

Microneedle arrays use our skin's own highly evolved and efficient immune response, making transdermal delivery as good or better than intramuscular injection.

MICRONEEDLE ADVANTAGES

• Thermostable

• 10-15 minute
painless
dissolve time

• Self-application

potential


LAB PROTOTYPE
MICRONEEDLE ARRAY
PATCH SHOWN
2 hands copy 3.jpg
• Dose sparing opportunity with highly customizable arrays and loading

• Novel and scalable
manufacturing

 
MN points 1.jpg

ELIMINATE COLD CHAIN

NO SHARPS DISPOSAL

RECONSTITUTION NOT REQUIRED

pandemic reach and readiness

Faster pandemic response with increased vaccination coverage into developing countries.

SCIENTIFIC COLLABORATORS

UC Irvine Institute for Immunology
UNCW Dept. of Chemistry and Biochemistry 
Queens University Belfast
SRI International Biosciences Division
TriLink BioTechnologies

PROOF OF CONCEPT

We have completed proof-of-concept validation in a collaborative university study, and are currently conducting immunogenicity studies with our Dissolving Microneedle Array Technology (DMAT). 

vaccination 3.jpg

COMMERCIALIZATION 

Our precision dispenser-based manufacturing process is scalable to high volume production. Contact us for partnership opportunities.